Who owns Avita Therapeutics Inc?
- Ticker: RCEL
- CUSIP Number: 05380c102
Tip: Access positions for across all investors
Analyze quarterly positions in Avita Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avita Therapeutics stock
Who bought or sold Avita Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 1.9M | $20M | 100% | Sep 2024 |
|
| BlackRock | 1.8M | $14M | 2% | Jun 2024 |
|
| Vanguard Group | 1.4M | $11M | -1% | Jun 2024 |
|
| Geode Capital Management | 594k | $6.4M | 1% | Sep 2024 |
|
| State Street Corporation | 508k | $4.0M | -46% | Jun 2024 |
|
| Soleus Capital Management | 267k | $2.1M | 256% | Jun 2024 |
|
| Essex Investment Management | 231k | $2.5M | 100% | Sep 2024 |
|
| Northern Trust | 217k | $2.3M | -1% | Sep 2024 |
|
| Morgan Stanley | 109k | $860k | 173% | Jun 2024 |
|
| AWM Investment Company | 98k | $1.1M | 34% | Sep 2024 |
|
| Goldman Sachs Group | 94k | $741k | 16% | Jun 2024 |
|
| Citadel Advisors | 90k | $961k | 17% | Sep 2024 |
|
| Jane Street | 89k | $958k | 33% | Sep 2024 |
|
| Legato Capital Management | 79k | $851k | 100% | Sep 2024 |
|
| Nuveen Asset Management | 72k | $568k | 0% | Jun 2024 |
|
| Charles Schwab Investment Management | 71k | $760k | 0% | Sep 2024 |
|
| D. E. Shaw & Co | 67k | $719k | -21% | Sep 2024 |
|
| Bank of New York Mellon | 53k | $569k | -27% | Sep 2024 |
|
| RMB Capital Management | 43k | $461k | 0% | Sep 2024 |
|
| Barclays | 38k | $402k | 340% | Sep 2024 |
|
| Rhumbline Advisers | 34k | $369k | -6% | Sep 2024 |
|
| Bank of America Corporation | 33k | $352k | -20% | Sep 2024 |
|
| Jpmorgan Chase & Co | 32k | $347k | 38% | Sep 2024 |
|
| Verition Fund Management | 26k | $204k | 100% | Jun 2024 |
|
| T. Rowe Price Associates | 20k | $213k | -1% | Sep 2024 |
|
| Citigroup | 18k | $198k | 168% | Sep 2024 |
|
| Wealth Enhancement Advisory Services | 16k | $128k | 100% | Jun 2024 |
|
| AQR Capital Management | 16k | $171k | -31% | Sep 2024 |
|
| MetLife Investment Advisors | 15k | $161k | 0% | Sep 2024 |
|
| Susquehanna International | 15k | $157k | 26% | Sep 2024 |
|
| Squarepoint Ops | 15k | $115k | 100% | Jun 2024 |
|
| Delta Investment Management | 14k | $155k | 100% | Sep 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 14k | $153k | 0% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 14k | $150k | 7% | Sep 2024 |
|
| Alliancebernstein | 14k | $108k | 100% | Jun 2024 |
|
| Deutsche Bank Aktiengesellschaft | 13k | $137k | 1% | Sep 2024 |
|
| Invesco | 11k | $123k | 4% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 11k | $86k | 100% | Jun 2024 |
|
| Geneos Wealth Management | 10k | $82k | 100% | Jun 2024 |
|
| Wells Fargo & Company | 9.9k | $106k | -3% | Sep 2024 |
|
| Quest Partners | 7.5k | $81k | 269% | Sep 2024 |
|
| New York State Common Retirement Fund | 5.3k | $57k | -44% | Sep 2024 |
|
| Tower Research Capital | 5.0k | $40k | 1917% | Jun 2024 |
|
| Macquarie Group | 4.3k | $34k | 338% | Jun 2024 |
|
| Huntington National Bank | 3.0k | $32k | 100% | Sep 2024 |
|
| Royal Bank of Canada | 2.8k | $33k | 8% | Sep 2024 |
|
| Russell Investments | 2.1k | $17k | 317% | Jun 2024 |
|
| Summit Investment Advisors | 2.1k | $22k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 1.9k | $20k | 0% | Sep 2024 |
|
| nVerses Capital | 900.00 | $9.6k | 100% | Sep 2024 |
|
| Amalgamated Bank | 848.00 | $9.0k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 373.00 | $4.0k | -89% | Sep 2024 |
|
| CWM | 320.00 | $3.0k | -26% | Sep 2024 |
|
| GAMMA Investing | 249.00 | $2.7k | 236% | Sep 2024 |
|
| NISA Investment Advisors | 163.00 | $1.7k | 987% | Sep 2024 |
|
| Jones Financial Companies, L.L | 134.00 | $1.4k | 100% | Sep 2024 |
|
| Cornerstone Planning Group | 130.00 | $1.3k | 100% | Sep 2024 |
|
| Lazard Asset Management | 128.00 | $1.0k | 100% | Sep 2024 |
|
| Parallel Advisors | 40.00 | $429.000000 | 0% | Sep 2024 |
|
| Rothschild Investment | 30.00 | $321.999000 | 100% | Sep 2024 |
|
| Sterling Capital Management | 26.00 | $279.000800 | 100% | Sep 2024 |
|
| Global Wealth Strategies & Associates | 20.00 | $214.000000 | 0% | Sep 2024 |
|
| Pnc Financial Services | 8.00 | $86.000000 | 0% | Sep 2024 |
|
| Capital Performance Advisors | 1.00 | $11.000000 | 100% | Sep 2024 |
|
Who sold out of Avita Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Silvercrest Asset Management Group | Mar 2024 | 242k | $3.9M |
| Rafferty Asset Management | Mar 2024 | 52k | $827k |
| Hussman Econometrics Advisors | Jun 2024 | 42k | $333k |
| Dimensional Fund Advisors | Jun 2024 | 23k | $180k |
| Clearline Capital | Jun 2024 | 21k | $164k |
| Two Sigma Advisers | Mar 2024 | 12k | $192k |
| Simplex Trading | Jun 2024 | 3.5k | $27k |
| Truvestments Capital | Mar 2024 | 655.00 | $11k |
| ICA Group Wealth Management | Mar 2024 | 500.00 | $8.0k |
| Pacer Advisors | Mar 2024 | 244.00 | $3.9k |
| Steward Partners Investment Advisory | Mar 2024 | 52.00 | $834.002000 |
| Ronald Blue Trust | Jun 2024 | 20.00 | $321.000000 |
| Cypress Capital | Jun 2024 | 10.00 | $79.000000 |